• Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences

    Source: Nasdaq GlobeNewswire / 06 Sep 2022 16:01:00   America/New_York

    CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in the following upcoming investor conferences:

    • H.C. Wainwright 24th Annual Global Investment Conference
      Tuesday, September 13, 2022
    • Morgan Stanley 20th Annual Global Healthcare Conference
      Wednesday, September 14, 2022 at 10:00 a.m. ET (Fireside Chat)

    A live audio webcast of the Morgan Stanley fireside chat will be available through the Investor Relations section of the Fulcrum website at https://ir.fulcrumtx.com/events-and-presentations. An archived replay will be available on the Company’s website for 30 days.

    About Fulcrum Therapeutics 
    Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet need. Fulcrum’s two lead programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease (SCD) and other hemoglobinopathies, including beta-thalassemia. The company’s proprietary product engine, FulcrumSeek™, identifies drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, please visit www.fulcrumtx.com.

    Contacts:

    Investors
    Stephanie Ascher
    Stern Investor Relations, Inc.
    stephanie.ascher@sternir.com
    212-362-1200

    Media
    Dee Smith
    Executive Director, Corporate Communications
    Fulcrum Therapeutics, Inc.
    dsmith@fulcrumtx.com
    202-746-1324


    Primary Logo

Share on,